July 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alphabet Inc. (“Alphabet” or “the Company”) (NASDAQ: GOOG). Investors who purchased Alphabet securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alphabet has violated federal… read more
July 17, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Celcuity Inc. (“Celcuity” or “the Company”) (NASDAQ: CELC). Investors who purchased Celcuity securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Celcuity has violated federal… read more
July 15, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FirstSun Capital Bancorp (“FirstSun” or “the Company”) (NASDAQ: FSUN). Investors who purchased FirstSun securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether FirstSun has violated… read more
July 15, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of HCA Healthcare, Inc. (“HCA” or “the Company”) (NYSE: HCA). Investors who purchased HCA securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether HCA has violated… read more
July 14, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of International Business Machines Corporation (“IBM” or “the Company”) (NYSE: IBM). Investors who purchased IBM securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether IBM has… read more
July 14, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AstraZeneca PLC (“AstraZeneca” or “the Company”) (NYSE: AZN). Investors who purchased AstraZeneca securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether AstraZeneca has violated federal… read more
July 14, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ionis Pharmaceuticals, Inc. (“Ionis” or “the Company”) (NASDAQ: IONS). Investors who purchased Ionis securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Ionis has violated… read more
July 14, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHR). Investors who purchased Phreesia securities prior to March 30, 2026, and continue to hold to the present, are encouraged to obtain additional information… read more
July 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Snowflake Inc. (“Snowflake Inc.” or “the Company”) (NYSE: SNOW). Investors who purchased Snowflake Inc. securities prior to June 27, 2023, and continue to hold to the present, are encouraged to obtain… read more
July 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Franklin Covey Co. (“Franklin Covey” or “the Company”) (NYSE: FC). Investors who purchased Franklin Covey securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Franklin… read more
July 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Solstice Advanced Materials, Inc. (“Solstice” or “the Company”) (NASDAQ: SOLS). Investors who purchased Solstice securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Solstice has… read more
July 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Graphic Packaging Holding Company (“Graphic Packaging” or “the Company”) (NYSE: GPK). Investors who purchased Graphic Packaging securities prior to February 4, 2025, and continue to hold to the present, are encouraged… read more
July 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GPGI, Inc. (“GPGI” or “the Company”) (NYSE: GPGI). Investors who purchased GPGI securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether GPGI has violated federal… read more
July 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Concentrix Corporation (“Concentrix” or “the Company”) (NASDAQ: CNXC). Investors who purchased Concentrix securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Concentrix has violated federal… read more
July 7, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Identiv, Inc. (“Identiv” or “the Company”) (NASDAQ: INVE). Investors who purchased Identiv securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Identiv has violated federal… read more
July 3, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of InMode Ltd. (“InMode” or “the Company”) (NASDAQ: INMD). Investors who purchased InMode securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether InMode has violated federal… read more
July 2, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ON Semiconductor Corporation (“Onsemi” or “the Company”) (NASDAQ: ON). Investors who purchased Onsemi securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Onsemi has violated… read more
July 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SES AI Corporation (“SES” or “the Company”) (NYSE: SES). Investors who purchased SES securities prior to January 29, 2025, and continue to hold to the present, are encouraged to obtain additional… read more
July 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of LKQ Corporation (“LKQ” or “the Company”) (NASDAQ: LKQ). Investors who purchased LKQ securities prior to February 27, 2023, and continue to hold to the present, are encouraged to obtain additional information… read more
July 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MercadoLibre, Inc. (“MercadoLibre” or “the Company”) (NASDAQ: MELI). Investors who purchased MercadoLibre securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether MercadoLibre has violated federal… read more
July 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Omeros Corporation (“Omeros” or “the Company”) (NASDAQ: OMER). Investors who purchased Omeros securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Omeros has violated federal… read more
July 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Ensign Group, Inc. (“Ensign Group” or “the Company”) (NASDAQ: ENSG). Investors who purchased Ensign Group securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
June 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alamos Gold Inc. (“Alamos” or “the Company”) (NYSE: AGI). Investors who purchased Alamos securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alamos has violated… read more
June 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DXC Technology Company (“DXC” or “the Company”) (NYSE: DXC). Investors who purchased DXC securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether DXC has violated… read more
June 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elastic N.V. (“Elastic” or “the Company”) (NYSE: ESTC). Investors who purchased Elastic securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Elastic has violated federal… read more
June 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GDS Holdings Limited (“GDS” or “the Company”) (NASDAQ: GDS). Investors who purchased GDS securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether GDS has violated… read more
June 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Starfighters Space, Inc. (“Starfighters” or “the Company”) (NYSE: FJET). Investors who purchased Starfighters securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Starfighters has violated… read more
June 25, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elicio Therapeutics, Inc. (“Elicio” or “the Company”) (NASDAQ: ELTX). Investors who purchased Elicio securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Elicio has violated… read more
June 25, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cerebras Systems Inc. (“Cerebras” or “the Company”) (NASDAQ: CBRS). Investors who purchased Cerebras securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Cerebras has violated… read more
June 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of JD.com, Inc. (“JD” or “the Company”) (NASDAQ: JD). Investors who purchased JD securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether JD has violated federal… read more